Eton Pharmaceuticals, Inc. (ETON)
55.36
+3.38
(+6.50%)
USD |
NASDAQ |
Oct 02, 16:00
55.37
+0.01
(+0.02%)
After-Hours: 20:00
Eton Pharmaceuticals Max Drawdown (5Y) : 79.94% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 79.94% |
| August 31, 2026 | 79.94% |
| July 31, 2026 | 79.94% |
| June 30, 2026 | 79.94% |
| May 31, 2026 | 79.94% |
| April 30, 2026 | 79.94% |
| March 31, 2026 | 79.94% |
| February 28, 2026 | 79.94% |
| January 31, 2026 | 79.94% |
| December 31, 2025 | 79.94% |
| November 30, 2025 | 79.94% |
| October 31, 2025 | 79.94% |
| September 30, 2025 | 79.94% |
| August 31, 2025 | 79.94% |
| July 31, 2025 | 79.94% |
| June 30, 2025 | 79.94% |
| May 31, 2025 | 79.94% |
| April 30, 2025 | 79.94% |
| March 31, 2025 | 79.94% |
| February 28, 2025 | 79.94% |
| January 31, 2025 | 79.94% |
| December 31, 2024 | 79.94% |
| November 30, 2024 | 79.94% |
| October 31, 2024 | 79.94% |
| September 30, 2024 | 79.94% |
| Date | Value |
|---|---|
| August 31, 2024 | 79.94% |
| July 31, 2024 | 79.94% |
| June 30, 2024 | 79.94% |
| May 31, 2024 | 79.94% |
| April 30, 2024 | 79.94% |
| March 31, 2024 | 79.94% |
| February 29, 2024 | 79.94% |
| January 31, 2024 | 79.94% |
| December 31, 2023 | 79.94% |
| November 30, 2023 | 79.94% |
| October 31, 2023 | 79.94% |
| September 30, 2023 | 79.94% |
| August 31, 2023 | 79.94% |
| July 31, 2023 | 79.94% |
| June 30, 2023 | 79.94% |
| May 31, 2023 | 79.94% |
| April 30, 2023 | 79.94% |
| March 31, 2023 | 79.94% |
| February 28, 2023 | 79.94% |
| January 31, 2023 | 79.94% |
| December 31, 2022 | 79.94% |
| November 30, 2022 | 79.94% |
| October 31, 2022 | 79.94% |
| September 30, 2022 | 79.74% |
| August 31, 2022 | 77.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc. | 58.95% |
| Elite Pharmaceuticals, Inc. | 87.92% |
| Daré Bioscience, Inc. | 97.24% |
| Liquidia Corp. | 92.71% |
| ANI Pharmaceuticals, Inc. | 72.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 46.40 |
| Beta (5Y) | 0.8981 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 69.75% |
| Historical Sharpe Ratio (5Y) | 0.794 |
| Historical Sortino (5Y) | 2.054 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.09% |